MicroPort CRM

MicroPort CRM, a subsidiary of MicroPort Medical Science and Technology Co., Ltd. (hereinafter referred to as "MicroPort®"), is primarily dedicated to the research, development, production, and global sales of implantable pacemakers, defibrillators, and cardiac resynchronization therapy (CRT) for heart failure, among other arrhythmia management solutions. Its product portfolio includes the PLATINIUMTM series of implantable defibrillator devices, as well as the ENOTM, TEOTM, and OTOTM pacemaker series, which are compatible with 1.5T and 3T full-body MRI. In 2021, the target group launched the new ALIZEATM and BOREATM pacemaker series, featuring Bluetooth technology and wireless remote monitoring capabilities.